IMUFLEX BLOOD BAG SYSTEM 1BBWGQ506A2

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2020-03-30 for IMUFLEX BLOOD BAG SYSTEM 1BBWGQ506A2 manufactured by Terumo Corporation.

Event Text Entries

[185915402] Investigation: the samples were not returned for investigation and the investigation was conducted based on the information provided. The lot number was unknown and possible lot numbers were estimated, which could be related to the customer, on the consignee list of the product in question (bb*wgq506a2); however, we were not able to find the data relating to the customer on the list. Review of the manufacturing record of the past year revealed that no abnormalities had been observed in the manufacturing process and the product had been manufactured as usual. The testing and inspection record of the past year was reviewed and confirmed that there had been no abnormalities in all release testing items including foreign matters. The product (bb*wgq506a2) conformed to the standards. A review of past complaints yielded one similar event. It was inferred that the cause of hemolysis/red-tinged plasma are the same as those stated in the root cause. Root cause: the reported incident may have occurred by a combination of the following common factors of hemolysis in blood products. Characteristics of blood there is a possibility of hemolysis if the blood of a donor has characteristics of red blood cell fragility. Bacterial contamination hemolysis is likely to occur if blood is contaminated with bacteria containing hemolysin. Excessively cooling blood is gradually congealed and eventually hemolyzed when it is cooled below -3? C. There is a possibility of hemolysis due to this factor if the blood bag is locally cooled in the refrigerator. Filter occlusion filtration time is extended because the filter is likely to be occluded, and furthermore, when red blood cells flow through such an occluded filter, physical stress on the red blood cells may cause hemolysis.
Patient Sequence No: 1, Text Type: N, H10


[185915403] The customer reported hemolysis (red tinged plasma) in a filtered whole blood unit. After centrifugation of leukoreduced filtered unit, hemolysis was observed on the post-filtration plasma. The unit involved had a prolonged filtration time of greater than 2 hours. The units were quarantine and destroyed. There was not a transfusion recipient or patient involved at the time of whole blood processing, therefore no patient information is reasonably known at the time of the event. The collection set is not available for return because it was discarded by the customer.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9681839-2020-00028
MDR Report Key9897382
Report SourceHEALTH PROFESSIONAL
Date Received2020-03-30
Date of Report2020-03-30
Date of Event2020-02-29
Date Mfgr Received2020-03-06
Date Added to Maude2020-03-30
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactYOSHIKI TAKAGI
Manufacturer Street818 MISONODAIRA
Manufacturer CityFUJINOMIYA 418-0004
Manufacturer CountryJP
Manufacturer Postal418-0004
Manufacturer Phone44277141
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameIMUFLEX BLOOD BAG SYSTEM
Generic NameIMUFLEX WB-RP BLOOD BAG SYSTEM WITH LR FILTER
Product CodeCAK
Date Received2020-03-30
Catalog Number1BBWGQ506A2
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerTERUMO CORPORATION
Manufacturer AddressFUJINOMIYA JP


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2020-03-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.